Related Experiment Videos
Laparotomy prevents lethal endotoxemia in a murine sequential insult model by an IL-10-dependent mechanism
M R Back1, T P Sarac, L L Moldawer
1Department of Surgery, University of Florida College of Medicine, Gainesville 32610-0286, USA.
Abstract:
Multiple organ dysfunction and death are common sequelae after mesenteric ischemia-reperfusion injury as seen with mesenteric revascularization and thoracoabdominal aortic aneurysm repair. A second insult such as bacterial pneumonia occurring subsequent to the ischemia-reperfusion injury may contribute to these untoward effects. We hypothesized the sequential visceral/lower torso ischemia-reperfusion and endotoxemia in a murine model would increase the magnitude of the proinflammatory cytokine response and decrease survival. C57BL/6 mice underwent 20 min of supraceliac occlusion (IR), sham laparotomy (LAP), or no initial insult (CTRL) followed by intraperitoneal injection of a lethal dose of endotoxin (LPS [lipopolysaccharide 50 mg/kg] or saline vehicle at 24 h. Serum cytokine levels were measured by enzyme-linked immunosorbent assay (IL-10, IL-6) or WEHI bioassay [tumor necrosis factor (TNF)], and survival was determined at 5 days. The role of IL-10 on the TNF response and survival was examined in a subset of mice given mouse anti IL-10 IgM (25 mg/kg intraperitoneally) 2 h prior to the initial insult. Survival after LPS was significantly different (P < 0.05) among the treatment groups (IR, 64%; LAP, 55%; CTRL, 11%) and appeared to trend directly with the magnitude of the initial operation. The serum IL-10 levels in the IR and LAP groups were significantly increased 4 h after the initial insult and remained elevated at 24 h. Peak serum TNF levels after LPS were significantly lower in the IR and LAP groups. Administration of anti IL-10 IgM resulted in uniform mortality and a significant increase in the peak TNF levels after LPS administration for all initial treatment groups. Endogenous production of IL-10 following laparotomy down-regulates the TNF response and improves survival after endotoxemia.
Insights
Sequential insults like ischemia-reperfusion and endotoxemia increase inflammation. Interleukin-10 (IL-10) production after surgery improves survival by reducing tumor necrosis factor (TNF) response.
Area of Science:
- Immunology
- Surgical Research
- Critical Care Medicine
Background:
- Mesenteric ischemia-reperfusion injury can lead to multiple organ dysfunction and death.
- Subsequent insults, such as bacterial pneumonia, can exacerbate outcomes after initial injury.
- The combined effects of sequential insults on inflammatory responses and survival are not fully understood.
Purpose of the Study:
- To investigate the impact of sequential visceral/lower torso ischemia-reperfusion and endotoxemia on proinflammatory cytokine response and survival in a murine model.
- To determine the role of interleukin-10 (IL-10) in modulating the tumor necrosis factor (TNF) response and survival following these sequential insults.
Main Methods:
- C57BL/6 mice underwent supraceliac aortic occlusion (ischemia-reperfusion, IR), sham laparotomy (LAP), or no initial insult (CTRL).
- Mice received a lethal dose of lipopolysaccharide (LPS) or saline vehicle 24 hours later.
- Serum cytokine levels (IL-10, IL-6, TNF) and 5-day survival were measured. Anti-IL-10 antibodies were used to assess IL-10's role.
Main Results:
- Survival after LPS was significantly higher in IR (64%) and LAP (55%) groups compared to CTRL (11%), correlating with initial operation magnitude.
- Serum IL-10 levels were significantly increased in IR and LAP groups post-insult.
- Peak serum TNF levels after LPS were significantly lower in IR and LAP groups.
- Administration of anti-IL-10 antibodies led to uniform mortality and increased peak TNF levels.
Conclusions:
- Endogenous IL-10 production following laparotomy down-regulates the TNF response.
- IL-10 plays a critical role in improving survival after endotoxemia following initial surgical insult.
- Targeting IL-10 may offer therapeutic potential in managing patients with sequential insults.